Hap Trading, LLC Biogen Inc. Call Options Transaction History

Hap Trading, LLC

$840 Billion
Q2 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $5.06 Million - $6.98 Million	-26,000 Reduced 43.55%	33,700 $449,000
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $487,604 - $579,852	2,600 Added 4.55%	59,700 $168,000
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $7.19 Million - $9.06 Million	37,100 Added 185.5%	57,100 $218,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $4.72 Million - $6.07 Million	-21,100 Reduced 51.34%	20,000 $134,000
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $7.27 Million - $9.48 Million	-25,700 Reduced 38.47%	41,100 $233,000
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $3.16 Million - $5.06 Million	-12,200 Reduced 15.44%	66,800 $942,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $12.6 Million - $14.8 Million	52,000 Added 192.59%	79,000 $689,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.49 Million - $2.24 Million	6,300 Added 30.43%	27,000 $267,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $3.1 Million - $3.58 Million	-11,700 Reduced 36.11%	20,700 $196,000
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $3.83 Million - $5.07 Million	14,800 Added 84.09%	32,400 $101,000
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $6.18 Million - $7.84 Million	-23,000 Reduced 56.65%	17,600 $288,000
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $3.21 Million - $4.44 Million	14,600 Added 56.15%	40,600 $869,000
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $3.39 Million - $3.8 Million	15,600 Added 150.0%	26,000 $202,000
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $2.25 Million - $3.53 Million	10,400 New	10,400 $30,000
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $2.51 Million - $3.17 Million	-9,000 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $2.64 Million - $3.45 Million	9,000 New	9,000 $240,000

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.13 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.08 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.74 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.34 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.07 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account